STREPTOCOCCAL BRONCHITIS

This adverse event was reported 9 times

These drugs are most commonly taken by patients reporting STREPTOCOCCAL BRONCHITIS:

# Drug Count
0 INFLIXIMAB 2
1 NIRMATRELVIR AND RITONAVIR 2
2 ALMOTRIPTAN 1
3 CALCIUM 1
4 CANAKINUMAB 1
5 CANDESARTAN 1
6 CYCLOBENZAPRINE 1
7 DESVENLAFAXINE 1
8 DESVENLAFAXINE SUCCINATE 1
9 DUPILUMAB 1
See all common drugs associated with STREPTOCOCCAL BRONCHITIS

STREPTOCOCCAL BRONCHITIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ALMOTRIPTAN 1 0.0009
1 EPTINEZUMAB-JJMR 1 0.0001
2 CANAKINUMAB 1 0.0001
3 INSTALAX POLYETHYLENE GLYCOL 3350 1 0.0001
4 POLYETHYLENE GLYCOL 400 1 0.0001
5 NIRMATRELVIR AND RITONAVIR 2 0.0000
6 DESVENLAFAXINE SUCCINATE 1 0.0000
7 CANDESARTAN 1 0.0000
8 CYCLOBENZAPRINE 1 0.0000
9 TOPIRAMATE 1 0.0000
See all drugs enriched for association with STREPTOCOCCAL BRONCHITIS